While the FDA first approved GLP-1s in 2005, 6% of Americans are now on medications like Ozempic, Wegovy, Mounjaro, and Zepbound, and 12% of US adults have tried a GLP-1and that number keeps climbing
At 1.0mg, you are drawing 40 units (0.40mL) from your vial
As a doctor, theres a lot of burden on your shoulders when you are prescribing something with insufficient evidence, but the patients insist on giving it a try. With no formal approvals surrounding their use from regulatory bodies like the Drugs Controller General of India (DCGI), they are considered off-label treatments
GLP-1 plays a crucial role in regulating blood sugar levels, insulin secretion, and appetite
Over two years, the average change in weight loss was 15.2% in those who received Wegovy versus 2.6% in people who received a placebo
In fact, many wellness enthusiasts find that using both creates a multi-layered approach to antioxidant support